Molecular Pathology is an emerging discipline with a rapidly increasing demand and increasing repertoire of available tests. The Molecular Pathology team is dedicated to improving patient outcomes and its service to its users by investigating and implementing new technologies and tests as they become clinically relevant.
The team is currently working towards the development of:
- Extended molecular testing for adult and paediatric CNS tumours.
- A custom RNA NGS panel for the detection of common RNA fusions in a range of solid tumour samples (replacement of current FISH technology).